Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
HSPG2 encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. Additionally we are shipping HSPG2 Kits (12) and HSPG2 Proteins (7) and many more products for this protein.
Showing 10 out of 55 products:
Bacteria Monoclonal HSPG2 Primary Antibody for IHC (fro), IF - ABIN114947
Couchman, Ljubimov: Mammalian tissue distribution of a large heparan sulfate proteoglycan detected by monoclonal antibodies. in Matrix (Stuttgart, Germany) 1989
Show all 6 references for ABIN114947
Nidogen-1 (show NID1 Antibodies) and nidogen-2 (show NID2 Antibodies) mRNAs were highly expressed in keratocytes, whereas perlecan was highly expressed in myofibroblasts.
RUS3108 is a novel perlecan-inducing compound which may prevent in-stent restenosis.
Knockdown of agrin (show AGRN Antibodies) and perlecan promoted a decrease on cell migration and adhesion, and on resistance of cells to cisplatin.
As five of the seven missense mutations in Schwartz-Jampel syndrome affect domain III of perlecan, domain III is likely to be essential for secretion of perlecan into the extracellular space.
Rare variants in the HSPG2 gene potentially contribute to the idiopathic scoliosis phenotype in a subset of patients with idiopathic scoliosis
The perlecan is the primary ECM (show MMRN1 Antibodies) molecule comprising intraepithelial stroma of the junctional epithelium, in which leukocytes may migrate on ECM (show MMRN1 Antibodies) scaffolds in intercellular space toward the surface of the gingival sulci or pockets.
We conclude that enzymatic processing of perlecan in the BM or territorial matrix by MMP-7 (show MMP7 Antibodies) as occurs in the invasive tumor microenvironment acts as a molecular switch to alter PCa (show FLVCR1 Antibodies) cell behavior and favor cell dispersion and invasiveness.
Mutant genes (CELA1 (show CELA1 Antibodies), HSPG2, and KCNK5 (show KCNK5 Antibodies)) in Balkan endemic nephropathy patients encode proteins involved in basement membrane/extracellular matrix and vascular tone, tightly connected to process of angiogenesis.
this study hypothesizes the transcriptional control of the HSPG2 gene in mast cells to synthesize these transcripts supports their stimulatory and specific role in wound healing and tissue regeneration.
Perlecan synthesized by smooth muscle cells differs from that synthesized by endothelial cells by possessing different signaling capabilities and thus differential modulation of cell adhesion, proliferation and growth factor signaling.
role for perlecan in chondrogenic and osteogenic events which drive discal development and ossification of the vertebral bodies.
Urinary perlecan laminin G-like 3 peptide and Ig kappa light chains were decreased in IgA nephropathy.
Hyperglycemia-induced structural changes in perlecan may result in a subendothelial matrix that is more favorable to retention of monocytes. 2 forms of perlecan exist in BAEC SEM, 1 with HS chains only and 1 with both HS and CS/DS chains.
results suggest that perlecan made by growth plate chondrocytes is a low affinity receptor for FGF-2 (show FGF2 Antibodies) and acts to sequester FGF-2 (show FGF2 Antibodies) away from the high affinity receptor
data show that growth plate perlecan binds to FGF-2 (show FGF2 Antibodies) by its heparan sulfate chains but can only deliver FGF-2 (show FGF2 Antibodies) to FGF receptors when its chondroitin sulfate chains are removed.
Perlecan is a defining factor in both the biochemical and biomechanical properties of the pericellular matrix.
Hspg2 inhibits autophagy to maintain muscle homeostasis in mouse soleus muscle.
Perlecan HS has significant roles in directing the development of posttraumatic OA, potentially via the alteration of FGF/HS/FGFR (show FGFR2 Antibodies) signaling.
An in situ hybridization study of perlecan, DMP1 (show DMP1 Antibodies), and MEPE (show MEPE Antibodies) in developing condylar cartilage of the fetal mouse mandible and limb bud cartilage.
LG3, through interactions with alpha2beta1 integrins on recipient-derived cells leading to activation of ERK1/2 (show MAPK1/3 Antibodies) and increased migration, favors myointimal thickening
Perlecan binds the clustering molecule gliomedin (show GLDN Antibodies) and enhances clustering of node of Ranvier components.
perlecan deficiency alters cartilage matrix patterning and, as we now show, coordinately influences bone formation and calcification
applied a fluorescent technique to older mice expressing or deficient for perlecan/HSPG2, a large heparan-sulfate proteoglycan normally secreted in osteocytic PCM (show PCMT1 Antibodies)
[review] Perlecan domain V is present acutely and chronically after ischemic stroke and could have a role in acute neuroprotection and chronic neurorepair at the site of stroke brain injury.
Synovial perlecan plays an important role in osteophyte development in osteoarthritis.
Perlecan supports the maintenance of brain and skin subendothelial basement membranes and promotes vasculo- and angiogenesis by modulating FGF-2 (show FGF2 Antibodies) function
This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and Transthyretin, etc. and plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and Tardive dyskinesia.
heparan sulfate proteoglycan 2
, basement membrane-specific heparan sulfate proteoglycan core protein-like
, basement membrane-specific heparan sulfate proteoglycan core protein
, endorepellin (domain V region)
, perlecan proteoglycan
, perlecan (heparan sulfate proteoglycan 2)